During the last three months, 7 analysts shared their evaluations of Kimberly-Clark KMB, revealing diverse outlooks from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 2 | 3 | 2 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 1 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 1 | 2 | 2 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $147.57, a high estimate of $165.00, and a low estimate of $130.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 1.34%.
Analyzing Analyst Ratings: A Detailed Breakdown
A clear picture of Kimberly-Clark's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Chris Carey | Wells Fargo | Lowers | Equal-Weight | $130.00 | $140.00 |
Korinne Wolfmeyer | Piper Sandler | Lowers | Overweight | $161.00 | $175.00 |
Nik Modi | RBC Capital | Maintains | Outperform | $165.00 | $165.00 |
Andrea Teixeira | JP Morgan | Lowers | Underweight | $140.00 | $142.00 |
Peter Grom | UBS | Lowers | Neutral | $151.00 | $153.00 |
Lauren Lieberman | Barclays | Raises | Equal-Weight | $144.00 | $135.00 |
Andrea Teixeira | JP Morgan | Raises | Underweight | $142.00 | $137.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Kimberly-Clark. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Kimberly-Clark compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Kimberly-Clark's stock. This comparison reveals trends in analysts' expectations over time.
Capture valuable insights into Kimberly-Clark's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Kimberly-Clark analyst ratings.
Unveiling the Story Behind Kimberly-Clark
With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Key Indicators: Kimberly-Clark's Financial Health
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Kimberly-Clark's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately -3.51% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Consumer Staples sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 18.32%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Kimberly-Clark's ROE stands out, surpassing industry averages. With an impressive ROE of 74.93%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Kimberly-Clark's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.27% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Kimberly-Clark's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 5.8.
Understanding the Relevance of Analyst Ratings
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.